Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evandro de Azambuja

Showing results (21-30 of 299) with videos related to

Pageof 30
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Authors' Reply To the Letters to the Editor by Puklin et al and by Iyengar and LigibelSamuel Martel, Matteo Lambertini, Evandro de Azambuja
Ecancermedicalscience|December 1, 2016
Phosphoethanolamine and the danger of unproven drugsNoam Pondé, Evandro de Azambuja, Felipe Ades
ESMO Open|November 18, 2020
CDK4/6 inhibition in HR-positive early breast cancer: are we putting all eggs in one basket?Elisa Agostinetto, Rafael Caparica, Evandro de Azambuja
ESMO Open|August 2, 2017
Male breast cancer: finding the way in this uncommon pathChristian Maurer, Samuel Martel, Evandro de Azambuja
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2020
Are We RESPECTing Older Patients With Breast Cancer?Evandro de Azambuja, Noam Pondé, Richard D Gelber
European Journal of Cancer (Oxford, England : 1990)|January 8, 2008
Current perspectives of epothilones in breast cancerFatima Cardoso, Evandro de Azambuja, Lissandra Dal Lago
Cancer Treatment Reviews|March 15, 2023
Optimizing treatment for HER2-positive HR-positive breast cancerVeronique Debien, Evandro de Azambuja, Martine Piccart-Gebhart
Future Oncology (London, England)|April 3, 2019
Pertuzumab in HER2-positive early breast cancer: current use and perspectivesDaniel Eiger, Noam Falbel Pondé, Evandro de Azambuja
ESMO Open|November 16, 2016
Twenty years of anti-HER2 therapy-associated cardiotoxicityNoam F Pondé, Matteo Lambertini, Evandro de Azambuja
Current Cancer Drug Targets|March 12, 2009
Beyond trastuzumab: overcoming resistance to targeted HER-2 therapy in breast cancerPhilippe L Bedard, Evandro de Azambuja, Fatima Cardoso
Pageof 30

Showing results (21-30 of 299) with videos related to

Sort By:
Pageof 30
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2022
Authors' Reply To the Letters to the Editor by Puklin et al and by Iyengar and LigibelSamuel Martel, Matteo Lambertini, Evandro de Azambuja
Ecancermedicalscience|December 1, 2016
Phosphoethanolamine and the danger of unproven drugsNoam Pondé, Evandro de Azambuja, Felipe Ades
ESMO Open|November 18, 2020
CDK4/6 inhibition in HR-positive early breast cancer: are we putting all eggs in one basket?Elisa Agostinetto, Rafael Caparica, Evandro de Azambuja
ESMO Open|August 2, 2017
Male breast cancer: finding the way in this uncommon pathChristian Maurer, Samuel Martel, Evandro de Azambuja
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2020
Are We RESPECTing Older Patients With Breast Cancer?Evandro de Azambuja, Noam Pondé, Richard D Gelber
European Journal of Cancer (Oxford, England : 1990)|January 8, 2008
Current perspectives of epothilones in breast cancerFatima Cardoso, Evandro de Azambuja, Lissandra Dal Lago
Cancer Treatment Reviews|March 15, 2023
Optimizing treatment for HER2-positive HR-positive breast cancerVeronique Debien, Evandro de Azambuja, Martine Piccart-Gebhart
Future Oncology (London, England)|April 3, 2019
Pertuzumab in HER2-positive early breast cancer: current use and perspectivesDaniel Eiger, Noam Falbel Pondé, Evandro de Azambuja
ESMO Open|November 16, 2016
Twenty years of anti-HER2 therapy-associated cardiotoxicityNoam F Pondé, Matteo Lambertini, Evandro de Azambuja
Current Cancer Drug Targets|March 12, 2009
Beyond trastuzumab: overcoming resistance to targeted HER-2 therapy in breast cancerPhilippe L Bedard, Evandro de Azambuja, Fatima Cardoso
Pageof 30